nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilutamide—Flutamide—CYP1B1—melanoma	0.0191	0.65	CrCbGaD
Nilutamide—Interstitial pneumonia—Temozolomide—melanoma	0.0152	0.021	CcSEcCtD
Nilutamide—Interstitial lung disease—Bleomycin—melanoma	0.0123	0.017	CcSEcCtD
Nilutamide—Interstitial lung disease—Carmustine—melanoma	0.0108	0.0149	CcSEcCtD
Nilutamide—Arthritis—Vemurafenib—melanoma	0.0108	0.0149	CcSEcCtD
Nilutamide—Lung disorder—Temozolomide—melanoma	0.0104	0.0144	CcSEcCtD
Nilutamide—Interstitial lung disease—Temozolomide—melanoma	0.0104	0.0144	CcSEcCtD
Nilutamide—Interstitial pneumonia—Docetaxel—melanoma	0.0101	0.014	CcSEcCtD
Nilutamide—Dry skin—Vemurafenib—melanoma	0.00959	0.0132	CcSEcCtD
Nilutamide—Weight decreased—Vemurafenib—melanoma	0.00818	0.0113	CcSEcCtD
Nilutamide—Phosphatase alkaline increased—Temozolomide—melanoma	0.00736	0.0102	CcSEcCtD
Nilutamide—Oedema peripheral—Vemurafenib—melanoma	0.00713	0.00984	CcSEcCtD
Nilutamide—Interstitial lung disease—Docetaxel—melanoma	0.00692	0.00955	CcSEcCtD
Nilutamide—Gynaecomastia—Carmustine—melanoma	0.00682	0.00941	CcSEcCtD
Nilutamide—Abnormal vision—Carmustine—melanoma	0.00665	0.00918	CcSEcCtD
Nilutamide—Arthritis—Bleomycin—melanoma	0.00652	0.009	CcSEcCtD
Nilutamide—Abnormal vision—Temozolomide—melanoma	0.00642	0.00887	CcSEcCtD
Nilutamide—Alopecia—Vemurafenib—melanoma	0.00639	0.00883	CcSEcCtD
Nilutamide—Blood alkaline phosphatase increased—Temozolomide—melanoma	0.00615	0.00849	CcSEcCtD
Nilutamide—Back pain—Vemurafenib—melanoma	0.00609	0.00841	CcSEcCtD
Nilutamide—Hot flush—Temozolomide—melanoma	0.00571	0.00789	CcSEcCtD
Nilutamide—Menopausal symptoms—Temozolomide—melanoma	0.00567	0.00782	CcSEcCtD
Nilutamide—Gastrointestinal haemorrhage—Carmustine—melanoma	0.00553	0.00764	CcSEcCtD
Nilutamide—Cough—Vemurafenib—melanoma	0.0055	0.00759	CcSEcCtD
Nilutamide—Aspartate aminotransferase increased—Dactinomycin—melanoma	0.00532	0.00735	CcSEcCtD
Nilutamide—Enzalutamide—ALB—melanoma	0.00527	0.179	CrCbGaD
Nilutamide—Bone pain—Docetaxel—melanoma	0.00511	0.00706	CcSEcCtD
Nilutamide—Enzalutamide—ABCB1—melanoma	0.00502	0.171	CrCbGaD
Nilutamide—Weight decreased—Bleomycin—melanoma	0.00496	0.00684	CcSEcCtD
Nilutamide—Pneumonia—Bleomycin—melanoma	0.00491	0.00678	CcSEcCtD
Nilutamide—Dry skin—Temozolomide—melanoma	0.0049	0.00677	CcSEcCtD
Nilutamide—Phosphatase alkaline increased—Docetaxel—melanoma	0.0049	0.00676	CcSEcCtD
Nilutamide—Aspartate aminotransferase increased—Temozolomide—melanoma	0.00481	0.00665	CcSEcCtD
Nilutamide—Alanine aminotransferase increased—Temozolomide—melanoma	0.00471	0.00651	CcSEcCtD
Nilutamide—Haematuria—Bleomycin—melanoma	0.00466	0.00643	CcSEcCtD
Nilutamide—Pneumonia—Dactinomycin—melanoma	0.00458	0.00633	CcSEcCtD
Nilutamide—Decreased appetite—Vemurafenib—melanoma	0.00447	0.00617	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Vemurafenib—melanoma	0.00444	0.00613	CcSEcCtD
Nilutamide—Constipation—Vemurafenib—melanoma	0.0044	0.00607	CcSEcCtD
Nilutamide—Hypoaesthesia—Bleomycin—melanoma	0.00436	0.00602	CcSEcCtD
Nilutamide—Hyperglycaemia—Carmustine—melanoma	0.00431	0.00595	CcSEcCtD
Nilutamide—Upper respiratory tract infection—Temozolomide—melanoma	0.00429	0.00593	CcSEcCtD
Nilutamide—Pneumonia—Carmustine—melanoma	0.00429	0.00592	CcSEcCtD
Nilutamide—Erectile dysfunction—Temozolomide—melanoma	0.00426	0.00588	CcSEcCtD
Nilutamide—Depression—Carmustine—melanoma	0.00425	0.00587	CcSEcCtD
Nilutamide—Weight decreased—Temozolomide—melanoma	0.00418	0.00577	CcSEcCtD
Nilutamide—Hyperglycaemia—Temozolomide—melanoma	0.00417	0.00575	CcSEcCtD
Nilutamide—Urinary tract infection—Carmustine—melanoma	0.00414	0.00572	CcSEcCtD
Nilutamide—Pneumonia—Temozolomide—melanoma	0.00414	0.00572	CcSEcCtD
Nilutamide—Depression—Temozolomide—melanoma	0.00411	0.00567	CcSEcCtD
Nilutamide—Blood alkaline phosphatase increased—Docetaxel—melanoma	0.00409	0.00564	CcSEcCtD
Nilutamide—Body temperature increased—Vemurafenib—melanoma	0.00406	0.00561	CcSEcCtD
Nilutamide—Urinary tract infection—Temozolomide—melanoma	0.004	0.00553	CcSEcCtD
Nilutamide—Alopecia—Bleomycin—melanoma	0.00387	0.00535	CcSEcCtD
Nilutamide—Hypoaesthesia—Carmustine—melanoma	0.00381	0.00526	CcSEcCtD
Nilutamide—Hot flush—Docetaxel—melanoma	0.0038	0.00525	CcSEcCtD
Nilutamide—Oedema peripheral—Carmustine—melanoma	0.00377	0.00521	CcSEcCtD
Nilutamide—Menopausal symptoms—Docetaxel—melanoma	0.00377	0.0052	CcSEcCtD
Nilutamide—Visual disturbance—Docetaxel—melanoma	0.00375	0.00518	CcSEcCtD
Nilutamide—Asthenia—Vemurafenib—melanoma	0.00369	0.00509	CcSEcCtD
Nilutamide—Visual impairment—Carmustine—melanoma	0.00369	0.00509	CcSEcCtD
Nilutamide—Hypoaesthesia—Temozolomide—melanoma	0.00368	0.00508	CcSEcCtD
Nilutamide—Urinary tract disorder—Temozolomide—melanoma	0.00365	0.00504	CcSEcCtD
Nilutamide—Oedema peripheral—Temozolomide—melanoma	0.00364	0.00503	CcSEcCtD
Nilutamide—Cardiac failure—Docetaxel—melanoma	0.00364	0.00503	CcSEcCtD
Nilutamide—Pruritus—Vemurafenib—melanoma	0.00364	0.00502	CcSEcCtD
Nilutamide—Urethral disorder—Temozolomide—melanoma	0.00363	0.00501	CcSEcCtD
Nilutamide—Alopecia—Dactinomycin—melanoma	0.00361	0.00499	CcSEcCtD
Nilutamide—Visual impairment—Temozolomide—melanoma	0.00356	0.00492	CcSEcCtD
Nilutamide—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.00356	0.00491	CcSEcCtD
Nilutamide—Ill-defined disorder—Bleomycin—melanoma	0.00354	0.00489	CcSEcCtD
Nilutamide—Anaemia—Bleomycin—melanoma	0.00353	0.00487	CcSEcCtD
Nilutamide—Diarrhoea—Vemurafenib—melanoma	0.00352	0.00486	CcSEcCtD
Nilutamide—Malaise—Bleomycin—melanoma	0.00344	0.00475	CcSEcCtD
Nilutamide—Leukopenia—Bleomycin—melanoma	0.00342	0.00472	CcSEcCtD
Nilutamide—Dizziness—Vemurafenib—melanoma	0.0034	0.00469	CcSEcCtD
Nilutamide—Alopecia—Carmustine—melanoma	0.00338	0.00467	CcSEcCtD
Nilutamide—Cough—Bleomycin—melanoma	0.00333	0.0046	CcSEcCtD
Nilutamide—Ill-defined disorder—Dactinomycin—melanoma	0.0033	0.00456	CcSEcCtD
Nilutamide—Anaemia—Dactinomycin—melanoma	0.00329	0.00454	CcSEcCtD
Nilutamide—Vomiting—Vemurafenib—melanoma	0.00327	0.00451	CcSEcCtD
Nilutamide—Alopecia—Temozolomide—melanoma	0.00327	0.00451	CcSEcCtD
Nilutamide—Dry skin—Docetaxel—melanoma	0.00326	0.0045	CcSEcCtD
Nilutamide—Chest pain—Bleomycin—melanoma	0.00325	0.00449	CcSEcCtD
Nilutamide—Rash—Vemurafenib—melanoma	0.00324	0.00448	CcSEcCtD
Nilutamide—Dermatitis—Vemurafenib—melanoma	0.00324	0.00447	CcSEcCtD
Nilutamide—Back pain—Carmustine—melanoma	0.00322	0.00445	CcSEcCtD
Nilutamide—Headache—Vemurafenib—melanoma	0.00322	0.00445	CcSEcCtD
Nilutamide—Discomfort—Bleomycin—melanoma	0.00321	0.00443	CcSEcCtD
Nilutamide—Malaise—Dactinomycin—melanoma	0.00321	0.00443	CcSEcCtD
Nilutamide—Aspartate aminotransferase increased—Docetaxel—melanoma	0.0032	0.00442	CcSEcCtD
Nilutamide—Leukopenia—Dactinomycin—melanoma	0.00319	0.0044	CcSEcCtD
Nilutamide—Alanine aminotransferase increased—Docetaxel—melanoma	0.00314	0.00433	CcSEcCtD
Nilutamide—Oedema—Bleomycin—melanoma	0.00311	0.0043	CcSEcCtD
Nilutamide—Back pain—Temozolomide—melanoma	0.00311	0.0043	CcSEcCtD
Nilutamide—Anaemia—Carmustine—melanoma	0.00308	0.00425	CcSEcCtD
Nilutamide—Nausea—Vemurafenib—melanoma	0.00305	0.00422	CcSEcCtD
Nilutamide—Discomfort—Dactinomycin—melanoma	0.00299	0.00413	CcSEcCtD
Nilutamide—Angina pectoris—Docetaxel—melanoma	0.00299	0.00413	CcSEcCtD
Nilutamide—Ill-defined disorder—Temozolomide—melanoma	0.00299	0.00412	CcSEcCtD
Nilutamide—Leukopenia—Carmustine—melanoma	0.00298	0.00412	CcSEcCtD
Nilutamide—Anaemia—Temozolomide—melanoma	0.00298	0.00411	CcSEcCtD
Nilutamide—Anorexia—Bleomycin—melanoma	0.00297	0.0041	CcSEcCtD
Nilutamide—Oedema—Dactinomycin—melanoma	0.0029	0.00401	CcSEcCtD
Nilutamide—Malaise—Temozolomide—melanoma	0.0029	0.00401	CcSEcCtD
Nilutamide—Leukopenia—Temozolomide—melanoma	0.00288	0.00398	CcSEcCtD
Nilutamide—Hypertension—Carmustine—melanoma	0.00288	0.00397	CcSEcCtD
Nilutamide—Chest pain—Carmustine—melanoma	0.00284	0.00392	CcSEcCtD
Nilutamide—Cough—Temozolomide—melanoma	0.00281	0.00388	CcSEcCtD
Nilutamide—Paraesthesia—Bleomycin—melanoma	0.0028	0.00386	CcSEcCtD
Nilutamide—Weight decreased—Docetaxel—melanoma	0.00278	0.00384	CcSEcCtD
Nilutamide—Hypertension—Temozolomide—melanoma	0.00278	0.00384	CcSEcCtD
Nilutamide—Dyspnoea—Bleomycin—melanoma	0.00278	0.00383	CcSEcCtD
Nilutamide—Anorexia—Dactinomycin—melanoma	0.00277	0.00382	CcSEcCtD
Nilutamide—Pneumonia—Docetaxel—melanoma	0.00276	0.0038	CcSEcCtD
Nilutamide—Oedema—Carmustine—melanoma	0.00272	0.00375	CcSEcCtD
Nilutamide—Discomfort—Temozolomide—melanoma	0.00271	0.00374	CcSEcCtD
Nilutamide—Decreased appetite—Bleomycin—melanoma	0.00271	0.00374	CcSEcCtD
Nilutamide—Dry mouth—Temozolomide—melanoma	0.00268	0.0037	CcSEcCtD
Nilutamide—Pain—Bleomycin—melanoma	0.00266	0.00368	CcSEcCtD
Nilutamide—Oedema—Temozolomide—melanoma	0.00263	0.00363	CcSEcCtD
Nilutamide—Anorexia—Carmustine—melanoma	0.00259	0.00358	CcSEcCtD
Nilutamide—Feeling abnormal—Bleomycin—melanoma	0.00257	0.00354	CcSEcCtD
Nilutamide—Hyperhidrosis—Temozolomide—melanoma	0.00254	0.00351	CcSEcCtD
Nilutamide—Decreased appetite—Dactinomycin—melanoma	0.00253	0.00349	CcSEcCtD
Nilutamide—Anorexia—Temozolomide—melanoma	0.0025	0.00346	CcSEcCtD
Nilutamide—Pain—Dactinomycin—melanoma	0.00248	0.00343	CcSEcCtD
Nilutamide—Rhinitis—Docetaxel—melanoma	0.00247	0.0034	CcSEcCtD
Nilutamide—Body temperature increased—Bleomycin—melanoma	0.00246	0.0034	CcSEcCtD
Nilutamide—Insomnia—Carmustine—melanoma	0.00246	0.0034	CcSEcCtD
Nilutamide—Hypoaesthesia—Docetaxel—melanoma	0.00245	0.00338	CcSEcCtD
Nilutamide—Paraesthesia—Carmustine—melanoma	0.00244	0.00337	CcSEcCtD
Nilutamide—Urinary tract disorder—Docetaxel—melanoma	0.00243	0.00335	CcSEcCtD
Nilutamide—Dyspnoea—Carmustine—melanoma	0.00242	0.00335	CcSEcCtD
Nilutamide—Oedema peripheral—Docetaxel—melanoma	0.00242	0.00335	CcSEcCtD
Nilutamide—Urethral disorder—Docetaxel—melanoma	0.00241	0.00333	CcSEcCtD
Nilutamide—Feeling abnormal—Dactinomycin—melanoma	0.00239	0.00331	CcSEcCtD
Nilutamide—Insomnia—Temozolomide—melanoma	0.00238	0.00328	CcSEcCtD
Nilutamide—Gastrointestinal pain—Dactinomycin—melanoma	0.00238	0.00328	CcSEcCtD
Nilutamide—Visual impairment—Docetaxel—melanoma	0.00237	0.00327	CcSEcCtD
Nilutamide—Decreased appetite—Carmustine—melanoma	0.00236	0.00326	CcSEcCtD
Nilutamide—Paraesthesia—Temozolomide—melanoma	0.00236	0.00326	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Carmustine—melanoma	0.00235	0.00324	CcSEcCtD
Nilutamide—Dyspnoea—Temozolomide—melanoma	0.00234	0.00323	CcSEcCtD
Nilutamide—Pain—Carmustine—melanoma	0.00232	0.00321	CcSEcCtD
Nilutamide—Constipation—Carmustine—melanoma	0.00232	0.00321	CcSEcCtD
Nilutamide—Dyspepsia—Temozolomide—melanoma	0.00231	0.00319	CcSEcCtD
Nilutamide—Abdominal pain—Dactinomycin—melanoma	0.0023	0.00317	CcSEcCtD
Nilutamide—Body temperature increased—Dactinomycin—melanoma	0.0023	0.00317	CcSEcCtD
Nilutamide—Decreased appetite—Temozolomide—melanoma	0.00228	0.00315	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Temozolomide—melanoma	0.00227	0.00313	CcSEcCtD
Nilutamide—Pain—Temozolomide—melanoma	0.00225	0.0031	CcSEcCtD
Nilutamide—Constipation—Temozolomide—melanoma	0.00225	0.0031	CcSEcCtD
Nilutamide—Feeling abnormal—Carmustine—melanoma	0.00224	0.00309	CcSEcCtD
Nilutamide—Asthenia—Bleomycin—melanoma	0.00223	0.00309	CcSEcCtD
Nilutamide—Gastrointestinal pain—Carmustine—melanoma	0.00222	0.00307	CcSEcCtD
Nilutamide—Pruritus—Bleomycin—melanoma	0.0022	0.00304	CcSEcCtD
Nilutamide—Alopecia—Docetaxel—melanoma	0.00217	0.003	CcSEcCtD
Nilutamide—Feeling abnormal—Temozolomide—melanoma	0.00217	0.00299	CcSEcCtD
Nilutamide—Abdominal pain—Carmustine—melanoma	0.00215	0.00297	CcSEcCtD
Nilutamide—Body temperature increased—Carmustine—melanoma	0.00215	0.00297	CcSEcCtD
Nilutamide—Gastrointestinal pain—Temozolomide—melanoma	0.00215	0.00297	CcSEcCtD
Nilutamide—Asthenia—Dactinomycin—melanoma	0.00208	0.00288	CcSEcCtD
Nilutamide—Abdominal pain—Temozolomide—melanoma	0.00208	0.00287	CcSEcCtD
Nilutamide—Body temperature increased—Temozolomide—melanoma	0.00208	0.00287	CcSEcCtD
Nilutamide—Back pain—Docetaxel—melanoma	0.00207	0.00286	CcSEcCtD
Nilutamide—Diarrhoea—Dactinomycin—melanoma	0.00199	0.00274	CcSEcCtD
Nilutamide—Vomiting—Bleomycin—melanoma	0.00198	0.00273	CcSEcCtD
Nilutamide—Anaemia—Docetaxel—melanoma	0.00198	0.00273	CcSEcCtD
Nilutamide—Rash—Bleomycin—melanoma	0.00196	0.00271	CcSEcCtD
Nilutamide—Dermatitis—Bleomycin—melanoma	0.00196	0.00271	CcSEcCtD
Nilutamide—Asthenia—Carmustine—melanoma	0.00195	0.00269	CcSEcCtD
Nilutamide—Syncope—Docetaxel—melanoma	0.00192	0.00265	CcSEcCtD
Nilutamide—Leukopenia—Docetaxel—melanoma	0.00192	0.00265	CcSEcCtD
Nilutamide—Asthenia—Temozolomide—melanoma	0.00189	0.0026	CcSEcCtD
Nilutamide—Loss of consciousness—Docetaxel—melanoma	0.00188	0.0026	CcSEcCtD
Nilutamide—Cough—Docetaxel—melanoma	0.00187	0.00258	CcSEcCtD
Nilutamide—Diarrhoea—Carmustine—melanoma	0.00186	0.00257	CcSEcCtD
Nilutamide—Pruritus—Temozolomide—melanoma	0.00186	0.00257	CcSEcCtD
Nilutamide—Nausea—Bleomycin—melanoma	0.00185	0.00255	CcSEcCtD
Nilutamide—Hypertension—Docetaxel—melanoma	0.00185	0.00255	CcSEcCtD
Nilutamide—Vomiting—Dactinomycin—melanoma	0.00185	0.00255	CcSEcCtD
Nilutamide—Rash—Dactinomycin—melanoma	0.00183	0.00253	CcSEcCtD
Nilutamide—Chest pain—Docetaxel—melanoma	0.00182	0.00252	CcSEcCtD
Nilutamide—Dizziness—Carmustine—melanoma	0.0018	0.00248	CcSEcCtD
Nilutamide—Diarrhoea—Temozolomide—melanoma	0.0018	0.00248	CcSEcCtD
Nilutamide—Dry mouth—Docetaxel—melanoma	0.00178	0.00246	CcSEcCtD
Nilutamide—Oedema—Docetaxel—melanoma	0.00175	0.00241	CcSEcCtD
Nilutamide—Dizziness—Temozolomide—melanoma	0.00174	0.0024	CcSEcCtD
Nilutamide—Vomiting—Carmustine—melanoma	0.00173	0.00239	CcSEcCtD
Nilutamide—Nausea—Dactinomycin—melanoma	0.00173	0.00238	CcSEcCtD
Nilutamide—Shock—Docetaxel—melanoma	0.00172	0.00237	CcSEcCtD
Nilutamide—Rash—Carmustine—melanoma	0.00171	0.00237	CcSEcCtD
Nilutamide—Dermatitis—Carmustine—melanoma	0.00171	0.00236	CcSEcCtD
Nilutamide—Headache—Carmustine—melanoma	0.0017	0.00235	CcSEcCtD
Nilutamide—Vomiting—Temozolomide—melanoma	0.00167	0.00231	CcSEcCtD
Nilutamide—Anorexia—Docetaxel—melanoma	0.00167	0.0023	CcSEcCtD
Nilutamide—Rash—Temozolomide—melanoma	0.00166	0.00229	CcSEcCtD
Nilutamide—Dermatitis—Temozolomide—melanoma	0.00166	0.00229	CcSEcCtD
Nilutamide—Headache—Temozolomide—melanoma	0.00165	0.00227	CcSEcCtD
Nilutamide—Nausea—Carmustine—melanoma	0.00161	0.00223	CcSEcCtD
Nilutamide—Insomnia—Docetaxel—melanoma	0.00158	0.00218	CcSEcCtD
Nilutamide—Paraesthesia—Docetaxel—melanoma	0.00157	0.00217	CcSEcCtD
Nilutamide—Nausea—Temozolomide—melanoma	0.00156	0.00215	CcSEcCtD
Nilutamide—Dyspnoea—Docetaxel—melanoma	0.00156	0.00215	CcSEcCtD
Nilutamide—Dyspepsia—Docetaxel—melanoma	0.00154	0.00212	CcSEcCtD
Nilutamide—Decreased appetite—Docetaxel—melanoma	0.00152	0.0021	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Docetaxel—melanoma	0.00151	0.00208	CcSEcCtD
Nilutamide—Pain—Docetaxel—melanoma	0.00149	0.00206	CcSEcCtD
Nilutamide—Constipation—Docetaxel—melanoma	0.00149	0.00206	CcSEcCtD
Nilutamide—Feeling abnormal—Docetaxel—melanoma	0.00144	0.00199	CcSEcCtD
Nilutamide—Gastrointestinal pain—Docetaxel—melanoma	0.00143	0.00197	CcSEcCtD
Nilutamide—Body temperature increased—Docetaxel—melanoma	0.00138	0.00191	CcSEcCtD
Nilutamide—Abdominal pain—Docetaxel—melanoma	0.00138	0.00191	CcSEcCtD
Nilutamide—Asthenia—Docetaxel—melanoma	0.00125	0.00173	CcSEcCtD
Nilutamide—Pruritus—Docetaxel—melanoma	0.00124	0.00171	CcSEcCtD
Nilutamide—Diarrhoea—Docetaxel—melanoma	0.0012	0.00165	CcSEcCtD
Nilutamide—Dizziness—Docetaxel—melanoma	0.00116	0.0016	CcSEcCtD
Nilutamide—Vomiting—Docetaxel—melanoma	0.00111	0.00153	CcSEcCtD
Nilutamide—Rash—Docetaxel—melanoma	0.0011	0.00152	CcSEcCtD
Nilutamide—Dermatitis—Docetaxel—melanoma	0.0011	0.00152	CcSEcCtD
Nilutamide—Headache—Docetaxel—melanoma	0.00109	0.00151	CcSEcCtD
Nilutamide—Nausea—Docetaxel—melanoma	0.00104	0.00143	CcSEcCtD
Nilutamide—AR—Integrated Breast Cancer Pathway—BRAF—melanoma	0.000474	0.00192	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	0.00047	0.00191	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—CASP8—melanoma	0.00047	0.00191	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—RB1—melanoma	0.000466	0.00189	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—CDH1—melanoma	0.000464	0.00188	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—melanoma	0.000461	0.00187	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—MYC—melanoma	0.000457	0.00185	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—STAT3—melanoma	0.000456	0.00185	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—ATM—melanoma	0.000446	0.00181	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	0.000444	0.0018	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—ACER3—melanoma	0.000436	0.00177	CbGpPWpGaD
Nilutamide—CYP2C8—Arachidonic acid metabolism—PTGS2—melanoma	0.000434	0.00176	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—CYP17A1—melanoma	0.000425	0.00173	CbGpPWpGaD
Nilutamide—CYP2C8—Metapathway biotransformation—CYP17A1—melanoma	0.00042	0.0017	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—APC—melanoma	0.000418	0.0017	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—EGFR—melanoma	0.000414	0.00168	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—EGF—melanoma	0.000413	0.00168	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—BCL2—melanoma	0.000403	0.00164	CbGpPWpGaD
Nilutamide—AR—Coregulation of Androgen receptor activity—AKT1—melanoma	0.000397	0.00161	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—MDM2—melanoma	0.000397	0.00161	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	0.000389	0.00158	CbGpPWpGaD
Nilutamide—CYP2C19—Arachidonic acid metabolism—PTGS2—melanoma	0.000387	0.00157	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	0.000383	0.00155	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—CYP17A1—melanoma	0.00038	0.00154	CbGpPWpGaD
Nilutamide—CYP2C19—Metapathway biotransformation—CYP17A1—melanoma	0.000374	0.00152	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	0.00037	0.0015	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—CXCL8—melanoma	0.000362	0.00147	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—CYP1B1—melanoma	0.000358	0.00145	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—CASP3—melanoma	0.000355	0.00144	CbGpPWpGaD
Nilutamide—CYP2C8—Metapathway biotransformation—CYP1B1—melanoma	0.000353	0.00143	CbGpPWpGaD
Nilutamide—CYP2C9—Arachidonic acid metabolism—PTGS2—melanoma	0.000353	0.00143	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	0.000352	0.00143	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—CYP17A1—melanoma	0.000346	0.00141	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—CASP3—melanoma	0.000346	0.00141	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—CCND1—melanoma	0.000346	0.0014	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—CTNNB1—melanoma	0.000343	0.00139	CbGpPWpGaD
Nilutamide—CYP2C9—Metapathway biotransformation—CYP17A1—melanoma	0.000341	0.00139	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	0.000334	0.00136	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—PTEN—melanoma	0.000334	0.00136	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—CTNNB1—melanoma	0.000334	0.00136	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—NFKB1—melanoma	0.000332	0.00135	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	0.000329	0.00134	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	0.000325	0.00132	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	0.000324	0.00132	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—NFKB1—melanoma	0.000324	0.00131	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—CYP1B1—melanoma	0.00032	0.0013	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	0.000317	0.00129	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—melanoma	0.000317	0.00129	CbGpPWpGaD
Nilutamide—AR—Gene Expression—RPS3—melanoma	0.000315	0.00128	CbGpPWpGaD
Nilutamide—CYP2C19—Metapathway biotransformation—CYP1B1—melanoma	0.000315	0.00128	CbGpPWpGaD
Nilutamide—AR—Gene Expression—SKI—melanoma	0.00031	0.00126	CbGpPWpGaD
Nilutamide—AR—Gene Expression—SNRPE—melanoma	0.00031	0.00126	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—VEGFA—melanoma	0.000302	0.00122	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	0.0003	0.00122	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—CDKN2B—melanoma	0.000295	0.0012	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	0.000294	0.0012	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—VEGFA—melanoma	0.000294	0.00119	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—AKT1—melanoma	0.000294	0.00119	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—CYP1B1—melanoma	0.000291	0.00118	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	0.00029	0.00118	CbGpPWpGaD
Nilutamide—CYP2C9—Metapathway biotransformation—CYP1B1—melanoma	0.000287	0.00117	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—VDR—melanoma	0.000287	0.00117	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	0.000287	0.00116	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	0.000284	0.00115	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—MYC—melanoma	0.000277	0.00113	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	0.000277	0.00113	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	0.000277	0.00112	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	0.000275	0.00112	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—MAPK1—melanoma	0.000271	0.0011	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—EGFR—melanoma	0.000271	0.0011	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—CUBN—melanoma	0.000271	0.0011	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	0.000264	0.00107	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—KRAS—melanoma	0.000256	0.00104	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—GPAM—melanoma	0.000254	0.00103	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—TNF—melanoma	0.000252	0.00102	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	0.00025	0.00101	CbGpPWpGaD
Nilutamide—AR—Gene Expression—NPPA—melanoma	0.000243	0.000986	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—CUBN—melanoma	0.000242	0.000982	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ACER3—melanoma	0.000239	0.000969	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	0.000236	0.00096	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—MYC—melanoma	0.00023	0.000933	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—TP53—melanoma	0.000228	0.000925	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—GPAM—melanoma	0.000226	0.000919	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	0.000225	0.000913	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	0.000225	0.000913	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—CUBN—melanoma	0.000221	0.000896	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—UGT2B10—melanoma	0.000218	0.000886	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.000216	0.000875	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—TNF—melanoma	0.000214	0.000869	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ACER3—melanoma	0.000213	0.000865	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	0.000212	0.000862	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—NOTCH1—melanoma	0.000212	0.000862	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—GPAM—melanoma	0.000206	0.000838	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—IL6—melanoma	0.000203	0.000825	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—HS3ST5—melanoma	0.000203	0.000824	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—PPARG—melanoma	0.0002	0.000813	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	0.000195	0.000792	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—UGT2B10—melanoma	0.000195	0.000791	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ACER3—melanoma	0.000194	0.000789	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—AKT1—melanoma	0.000192	0.000781	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.000192	0.000781	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—melanoma	0.000189	0.000767	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—HS3ST5—melanoma	0.000181	0.000736	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—UGT2B10—melanoma	0.000178	0.000721	CbGpPWpGaD
Nilutamide—AR—Gene Expression—HDAC2—melanoma	0.000178	0.000721	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.000175	0.000712	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—HS3ST5—melanoma	0.000165	0.000671	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	0.000163	0.000663	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	0.000159	0.000647	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PLCB4—melanoma	0.000154	0.000625	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—FASN—melanoma	0.000151	0.000613	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	0.000146	0.000592	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—SLC6A11—melanoma	0.000145	0.000587	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PIP4K2A—melanoma	0.000145	0.000587	CbGpPWpGaD
Nilutamide—AR—Gene Expression—CDKN2B—melanoma	0.000142	0.000576	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—MTAP—melanoma	0.000141	0.000571	CbGpPWpGaD
Nilutamide—AR—Gene Expression—VDR—melanoma	0.000138	0.000562	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	0.000138	0.000558	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PLCB4—melanoma	0.000137	0.000557	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—FASN—melanoma	0.000135	0.000547	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	0.000133	0.00054	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PIP4K2A—melanoma	0.000129	0.000524	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—SLC6A11—melanoma	0.000129	0.000524	CbGpPWpGaD
Nilutamide—AR—Gene Expression—PRKCA—melanoma	0.000128	0.000518	CbGpPWpGaD
Nilutamide—AR—Gene Expression—ERCC2—melanoma	0.000127	0.000514	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—MTAP—melanoma	0.000126	0.00051	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PHGDH—melanoma	0.000125	0.000509	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—LUM—melanoma	0.000125	0.000509	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PLCB4—melanoma	0.000125	0.000508	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—HPSE—melanoma	0.000123	0.000499	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—FASN—melanoma	0.000123	0.000499	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	0.000123	0.000498	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CUBN—melanoma	0.000121	0.00049	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PIP4K2A—melanoma	0.000118	0.000478	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—SLC6A11—melanoma	0.000118	0.000478	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—SDHD—melanoma	0.000117	0.000473	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—BSG—melanoma	0.000117	0.000473	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CSPG4—melanoma	0.000117	0.000473	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—MTAP—melanoma	0.000114	0.000465	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—MYC—melanoma	0.000114	0.000464	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GPAM—melanoma	0.000113	0.000458	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PHGDH—melanoma	0.000112	0.000454	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—LUM—melanoma	0.000112	0.000454	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	0.000112	0.000454	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—HPSE—melanoma	0.00011	0.000446	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CUBN—melanoma	0.000108	0.000437	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—BSG—melanoma	0.000104	0.000422	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—SDHD—melanoma	0.000104	0.000422	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CSPG4—melanoma	0.000104	0.000422	CbGpPWpGaD
Nilutamide—AR—Gene Expression—NOTCH1—melanoma	0.000102	0.000415	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—LUM—melanoma	0.000102	0.000414	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PHGDH—melanoma	0.000102	0.000414	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GPAM—melanoma	0.000101	0.000409	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—HPSE—melanoma	0.0001	0.000406	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CUBN—melanoma	9.82e-05	0.000399	CbGpPWpGaD
Nilutamide—AR—Gene Expression—PPARG—melanoma	9.64e-05	0.000392	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PLA2G6—melanoma	9.6e-05	0.00039	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—SDHD—melanoma	9.49e-05	0.000385	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—BSG—melanoma	9.49e-05	0.000385	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CSPG4—melanoma	9.49e-05	0.000385	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GPAM—melanoma	9.19e-05	0.000373	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—VCAN—melanoma	8.62e-05	0.00035	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PLA2G6—melanoma	8.57e-05	0.000348	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	8.16e-05	0.000331	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—melanoma	7.88e-05	0.00032	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PLA2G6—melanoma	7.81e-05	0.000317	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—VCAN—melanoma	7.7e-05	0.000312	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	7.29e-05	0.000296	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CYP17A1—melanoma	7.28e-05	0.000295	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	7.18e-05	0.000291	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	7.08e-05	0.000288	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	7.03e-05	0.000285	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—VCAN—melanoma	7.02e-05	0.000285	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GNA11—melanoma	6.87e-05	0.000279	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—FASN—melanoma	6.72e-05	0.000273	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	6.64e-05	0.00027	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—SLC5A5—melanoma	6.61e-05	0.000269	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CYP17A1—melanoma	6.49e-05	0.000264	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	6.41e-05	0.00026	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	6.4e-05	0.00026	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GNAQ—melanoma	6.39e-05	0.000259	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CD44—melanoma	6.39e-05	0.000259	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	6.32e-05	0.000257	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	6.25e-05	0.000254	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	6.2e-05	0.000252	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GNA11—melanoma	6.13e-05	0.000249	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CYP1B1—melanoma	6.12e-05	0.000249	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—FASN—melanoma	6e-05	0.000244	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CYP17A1—melanoma	5.92e-05	0.00024	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—SLC5A5—melanoma	5.9e-05	0.00024	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	5.84e-05	0.000237	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	5.76e-05	0.000234	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CD44—melanoma	5.7e-05	0.000231	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GNAQ—melanoma	5.7e-05	0.000231	CbGpPWpGaD
Nilutamide—AR—Gene Expression—MAPK3—melanoma	5.65e-05	0.00023	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GNA11—melanoma	5.59e-05	0.000227	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	5.58e-05	0.000227	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	5.53e-05	0.000225	CbGpPWpGaD
Nilutamide—AR—Gene Expression—MYC—melanoma	5.5e-05	0.000223	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—FASN—melanoma	5.47e-05	0.000222	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CYP1B1—melanoma	5.47e-05	0.000222	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	5.4e-05	0.000219	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—SLC5A5—melanoma	5.38e-05	0.000219	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GNAQ—melanoma	5.2e-05	0.000211	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CD44—melanoma	5.2e-05	0.000211	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	5.09e-05	0.000207	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	5.04e-05	0.000205	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ABCB1—melanoma	5.04e-05	0.000205	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CYP1B1—melanoma	4.98e-05	0.000202	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.82e-05	0.000196	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PRKCA—melanoma	4.64e-05	0.000188	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ERCC2—melanoma	4.6e-05	0.000187	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ABCB1—melanoma	4.5e-05	0.000183	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.4e-05	0.000179	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PRKCA—melanoma	4.14e-05	0.000168	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ERCC2—melanoma	4.11e-05	0.000167	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ABCB1—melanoma	4.1e-05	0.000167	CbGpPWpGaD
Nilutamide—AR—Gene Expression—AKT1—melanoma	3.81e-05	0.000155	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.81e-05	0.000155	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PRKCA—melanoma	3.78e-05	0.000153	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ERCC2—melanoma	3.75e-05	0.000152	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PIK3CG—melanoma	3.64e-05	0.000148	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PPARG—melanoma	3.51e-05	0.000142	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.4e-05	0.000138	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PIK3CG—melanoma	3.24e-05	0.000132	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PIK3CD—melanoma	3.2e-05	0.00013	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ALB—melanoma	3.15e-05	0.000128	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PPARG—melanoma	3.13e-05	0.000127	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.1e-05	0.000126	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PIK3CG—melanoma	2.96e-05	0.00012	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PPARG—melanoma	2.86e-05	0.000116	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PIK3CD—melanoma	2.85e-05	0.000116	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ALB—melanoma	2.82e-05	0.000114	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PIK3CB—melanoma	2.79e-05	0.000113	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PTGS2—melanoma	2.76e-05	0.000112	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PIK3CD—melanoma	2.6e-05	0.000106	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ALB—melanoma	2.57e-05	0.000104	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PIK3CB—melanoma	2.49e-05	0.000101	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PTGS2—melanoma	2.46e-05	0.0001	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PTEN—melanoma	2.41e-05	9.77e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PIK3CB—melanoma	2.27e-05	9.2e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PTGS2—melanoma	2.25e-05	9.12e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PTEN—melanoma	2.15e-05	8.72e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PTEN—melanoma	1.96e-05	7.95e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PIK3CA—melanoma	1.7e-05	6.89e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PIK3CA—melanoma	1.52e-05	6.15e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—AKT1—melanoma	1.39e-05	5.63e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PIK3CA—melanoma	1.38e-05	5.61e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—AKT1—melanoma	1.24e-05	5.03e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—AKT1—melanoma	1.13e-05	4.58e-05	CbGpPWpGaD
